{
  "query": "Assess structural feasibility of Liposomal Upadacitinib",
  "molecule_name": "Upadacitinib",
  "formulation_type": "Liposomal Gel",
  "target_condition": "Atopic Dermatitis",
  "side_effect_mitigation": "Acneiform Eruption",
  "context": {
    "source": "SEP-02 Control Hypothesis",
    "evidence": [
      "Upadacitinib treatment showed higher rates of acne (15-17%) compared to Dupilumab in Heads Up study.",
      "Acne events were primarily inflammatory papules on face and trunk.",
      "Mechanism of JAK inhibitor-induced acne is linked to follicular unit intrusion."
    ]
  }
}